EAHAD/LinkedIn
Aug 3, 2026, 12:44
Replaying the CSL Symposium on Gene Therapy Durability in Haemophilia – EAHAD
European Association for Haemophilia and Allied Disorders (EAHAD) shared a post on LinkedIn:
“Missed the CSL symposium on ‘Durability of gene therapy in haemophilia? Bridging trial results with clinical practice’ at EAHAD 2026?
The full session is now available on the EAHAD Academy.
Replay the session.
Free access”
Stay updated with Hemostasis Today.
-
Sep 23, 2026, 05:54Bringing the Global Thrombosis and Haemostasis Community Together in 2027 – ISTH
-
Sep 23, 2026, 04:34David Akande: When Sickle Cell Crises Have No Clear Trigger
-
Sep 23, 2026, 04:13Jean Connors: Safety of Heparin Re-Exposure in Patients with Remote HIT
-
Sep 23, 2026, 04:09Beth Psaila: Applications Now Open for the Gordon Research Conference on Megakaryocytes and Platelets
-
Sep 23, 2026, 03:27Abbie Newton: How Better Data Can Reduce Platelet Wastage
-
Sep 23, 2026, 03:01Suvro Sankha Datta: Rapid Blood Group Genotyping Using Gold Oligo Nanonet Assembly
-
Sep 23, 2026, 02:55Asghar Muhammad: Exploring New Ways to Expand Blood Transfusion Compatibility
-
Sep 23, 2026, 02:49Bianca Rocca: Personalized Cardiovascular Pharmacotherapy in the September 2026 EHJ Issue
-
Sep 23, 2026, 02:35Udaya RajBhandari: A Hidden Risk of Repeated Transfusions in β Thalassemia